Health trajectories of women who used cocaine and/or cannabis during pregnancy. Retrospective cohort study in La Pampa, Argentina
DOI:
https://doi.org/10.31053/1853.0605.v77.n2.26838Keywords:
cocaine, cannabis, pregnancy, health care (Public Health), hospitalizationAbstract
Introduction: the use of cocaine and cannabis during pregnancy is a growing problem, of importance for the World Public Health. Women can present a wide range of complications during pregnancy and perinatally, although knowledge about evolution thereafter is scarce. Objectives: to describe and compare health trajectories up to 4 years pospartum of user and not user women of cocaine and/or cannabis during pregnancy. Methods: retrospective cohort study with a comparison group consisting of 2 not users women for each user during pregnancy. User women were detected in Neonatology Division of a public Hospital with an urine pospartum test, between 2009 and 2013. Results: 29 women cocaine and/or cannabis users during pregnancy, and 58 not users were evaluated. In the first group, 93% women were polydrug users. Users had higher frequency of: history of violence in childhood ((p<0,001), previous (p<0,0045) and acquired (p<0,0007) disease, medical (p<0,0001) and odontological (p=0,0002) emergency consultations, hospitalizations (p<0,0001), and violent deaths in relatives, compared with non users.
Conclusions: women who used cocaine and/or cocaine during pregnancy had a greater history of violence and illness, emergency medical and dental consultation, hospitalization and deaths, than non users. Injuries where the main cause of hospitalization. In the variables evaluated, the differences between consumers and non-consumers of pregnancy were significative.
Downloads
References
2. Chiandetti A, Hernandez G, Mercadal-Hally M, “et al”. Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers. Reproductive Health. 2017;14:137.
3. Roca Comas A, Vila Domènech JS, Massa Solé J, “et al” Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time of birth. Minerva Pediatr. 2017 Feb 7. doi: 10.23736/S0026-4946.17.04664-3.
4. Magri R, Míguez H, Parodi V, “et al”. Consumo de alcohol y otras drogas en embarazadas. Arch. Pediatr. Urug. 2007;78( 2 ): 122-132.
5. Villarreal Marina, Ré Silvina. Detección de drogas ilícitas en la orina en el Servicio de Neonatología, Hospital Molas. Arch. argent. pediatr. 2013;111(3): 232-236.
6. García- Algar O, Vall Combelles O, Puig Solab C, Mur Sierra A, Scaravellid G, Pacificie G, Monleón Getino T, Pichinie S. Exposición prenatal a drogas de abuso a través del análisis de meconio en una población de bajo nivel socioeconómico en Barcelona. An Pediatr (Barc). 2009;70(2):151–158.
7. Goel N, Beasley D, Rajkumar V, “et al”. Perinatal outcome of illicit substance abuse in pregnancy-comparative and temporary socio-clinical profile in the UK. Eur J Pediatr 2011;170(2):199-205.
8. Garcia Garcia J, Campistol Mas E, López-Vilchez MÁ, “et al”. Analysis of prenatal abuse in catalonia between the years 2011 and 2014. An Pediatr (Barc). 2018;88(3):150-159
9.Onah MN, Field S, van Heyningen T, “et al”. Predictors of alcohol and other drug use among pregnant women in a peri-urban South African setting. International Journal of Mental Health Systems. 2016;10:38..
10. Rocha P, Britto e Alves MT, Chagas D, “et al”. Prevalência e fatores associados ao uso de drogas ilícitas em gestantes da coorte BRISA. Cad. Saúde Pública. 2016; 32(1): e00192714.
11. Serino D, Peterson BS, Rosen TS. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. J Dual Diagn. 2018; Apr 25:0. doi: 10.1080/15504263.2018.1468946.
12. Oga EA, Mark K, Coleman-Cowger VH. Cigarette Smoking Status and Substance Use in Pregnancy. Matern Child Health J. 2018; Jun 7. doi: 10.1007/s10995-018-2543-9.
13. Proctor LJ, Lewis T, Roesch S, “et al”. Child maltreatment and age of alcohol and marijuana initiation in high-risk youth. Addict Behav. 2017;75:64-69.
14. Gunn JKL, Rosales CB, Center KE, “et al”. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. doi:10.1136/bmjopen-2015- 009986.
15. Bonello MR, Xu F, Li Z, “et al”. Mental and Behavioral Disorders Due to Substance Abuse and Perinatal Outcomes: A Study Based on Linked Population Data in New South Wales, Australia. International Journal of Environmental Research and Public Health 2014;11(5):4991-5005.
16. Forray A, Merry B, Lin H, “et al”. Perinatal Substance Use: A Prospective Evaluation of Abstinence and Relapse. Drug and alcohol dependence. 2015;150:147-155
17. Villarreal M, Belmonte V, Abdala A, Olivares JL. Trayectorias sanitarias durante 4 años de niños expuestos prenatalmente a cocaína y/o cannabis. Estudio de cohorte retrospectivo en La Pampa, Argentina. Arch Argent Pediatr 2019;117(6):360-367. Disponible en: https://www.sap.org.ar/uploads/archivos/general/files_ao_villarrealpdf_1570479951.pdf
18. Kendler KS, Ohlsson H, Svikis DS, “et al”. The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-relative, Co-spouse, and Within-Individual Analysis. Am J of Psychiatry. 2017;174(10):954-962.
19. Coleman-Cowger VH, Oga E, Peters EN, Mark K. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol. 2018;68:84-90.
20. Alvarez-Alonso MJ, Jurado-Barba R, Martínez-Martín N, “et al”. Association between maltreatment and polydrug use among adolescents. Child Abuse & Neglect. 2016;51:379-389.
21. Mills, R., Kisely, S., Alati, R., “et al”. Child maltreatment and cannabis use in young adulthood: a birth cohort study. Addiction 2017; 112(3):494–501.
22. Mendoza-Meléndez MÁ, Cepeda A, Frankeberger J “et al”. History of child sexual abuse among women consuming illicit substances in Mexico City. J Subst Use. 2018;23(5):520–527.
23. Johri M, Morales RE, Boivin J-F, “et al”. Increased risk of miscarriage among women experiencing physical or sexual intimate partner violence during pregnancy in Guatemala City, Guatemala: cross-sectional study. BMC Pregnancy and Childbirth. 2011;11:49.
24. Martin SL, Beaumont JL, Kupper LL. Substance use before and during pregnancy: links to intimate partner violence. Am J Drug Alcohol Abuse. 2003;29(3):599–617.
25. Olley BO, Seedat S, Gxamza F “et al”. Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care. 2005;17(1):1–9.
26. Choenni V, Hammink A, van de Mheen D. Association Between Substance Use and the Perpetration of Family Violence in Industrialized Countries: A Systematic Review. Trauma Violence Abuse. 2017;18(1):37-50.
27. Oliveira TA, Bersusa AA, Santos TF, “et al”. Perinatal Outcomes in Pregnant Women Users of Illegal Drugs. Rev Bras Ginecol Obstet. 2016;38(4):183-8.
28. De Macêdo VC, de Lira PIC, de Frias PG, “et al”. Risk factors for syphilis in women: case-control study. Revista de Saúde Pública. 2017;51:78.
29. Babatunde VD, Menendez ME, Ring D. Does Illicit Drug Use Influence Inpatient Adverse Events, Death, Length of Stay, and Discharge After Orthopaedic Trauma? J Surg Orthop Adv.2016; 25(1):41-8.
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
